Experimental disease models of influenza virus infections: Recent developments

Drug Discovery Today: Disease Models

Volumn 1, Issue 1, 2004, Pages 57-63

  Sidwell, Robert W ^a   Smee, Donald F ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; AMANTADINE; CYCLOPHOSPHAMIDE; ESCHERICHIA COLI ENDOTOXIN; MESSENGER RNA; RIMANTADINE; SIALIDASE; VIRUS RNA; ZANAMIVIR;

ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; AVIAN INFLUENZA; B LYMPHOCYTE; CELL CULTURE; COLORIMETRY; CYTOPATHOGENIC EFFECT; DRUG INHIBITION; ENCEPHALITIS; GENE SEQUENCE; GENETIC ENGINEERING; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; NONHUMAN; REVIEW; SPECTROPHOTOMETRY; SUDDEN INFANT DEATH SYNDROME; T LYMPHOCYTE;

EID: 23744516061     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2004.01.003     Document Type: Review

References (26)

1. Anon. (2003) Update: influenza activity-United States, 2003-2004 season. Morb. Mortal. Weekly. Rep. 12, 1197-1202
2. Sidwell, R.W. and Smee, D.E (2000) In vitro and in vivo assay systems for study of influenza virus inhibitors. Antiviral Res. 48, 1-16
3. R.W. Sidwell. (2001) A consideration of animal models used for study of influenza inhibitors. In: A. Osterhaus, N. Cox, A. Hampton (Eds.), Proc. Options Control Influenza, pp. 835-838. Excerpta Medica
4. Schmidtke, M. et al. (2001) A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. J. Virol. Methods 95, 133-143
5. Smee, D.F. et al. (2002) Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. J. Virol. Methods 106, 71-79
6. Gubareva, L.V. et al. (2002) Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res. 53, 47-61
7. Wagaman, P.C. et al. (2002) Development of a novel influenza A antiviral assay. J. Virol. Methods 105, 105-114
8. Uchide, N. et al. (2002) Semi-quantitative RT-PCR-based assay, improved by Southern hybridization technique, for polarity-specific influenza virus RNAs in cultured cells. J. Virol. Methods 106, 125-134
9. Tumpey, T.M. et al. (2002) Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 99, 13849-13854
10. Shinjoh, M. et al. (2002) Prophylaxis and treatment of influenza encephalitis in an experimental mouse model. J. Med. Virol. 67, 406-417
11. Mori, I. et al. (2002) Successful protection by amantadine hydrochloride against lethal encephalitis caused by a highly neurovirulent recombinant influenza A virus in mice. Virology 303, 287-296
12. Mori, I. et al. (1999) Selective targeting of habenular, thalamic midline and monaminergic brainstem neurons by neurotropic influenza A virus in mice. J. Neurovirol. 5, 355-362
13. Aronsson, F. et al. (2003) Invasion and persistence of the neuroadapted influenza virus A.WSN/33 in the mouse olfactory system. Viral Immunol. 16, 415-423
14. Park, C.H. et al. (2002) The invasion routes of neurovirulent A/Hong Kong/483/97 (H5N1) influenza virus into the central nervous system after respiratory infection in mice. Arch. Virol. 147, 1425-1436
15. Shinya, K. et al. (2000) Avian influenza virus intranasally inoculated infects the central nervous system of mice through the general visceral afferent nerve. Arch. Virol. 145, 187-195
16. Sedger, L.M. et al. (2002) Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha. J. Immunol. 169, 6193-6201
17. Lund, F.E. et al. (2002) Lymphotoxin-alpha-deficient mice make delayed but effective T- and B-cell responses to influenza. J. Immunol. 169, 5236-5243
18. Zitzow, L.A. et al. (2002) Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J. Virol. 76, 4420-4429
19. Blood-Siegfried, J. et al. (2002) Synergistic effect of influenza A virus on endotoxin-induced mortality in rat pups: a potential model for sudden infant death syndrome. Ped. Res. 52, 481-490
20. Daniels, M.J. et al. (2003) Kinetic profile of influenza virus infection in three rat strains. Comp. Med. 53, 293-298
21. Sadowski, W. et al. (1987) Cotton rat (Sigmodon hispidus) as an experimental model for study of respiratory tract viral infections in man. II. Influenza virus A and B. Med. Dosw. Mikrobiol. 39, 43-55
22. Ottolini, M.G. et al. (1999) Measuring the inflammatory response in influenza-modeling human disease. In: Proceedings of the 17th European Society for Pediat. Infect. Dis., Crete, Greece
23. Ottolini, M.G. et al. (2003) Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model. Pediat. Pulmonol. 36, 290-294
24. Sidwell, R.W. et al. (2002) Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors. Antiviral Chem. Chemother. 12, 359-365
25. Sidwell, R.W. et al. (2003) Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812). Antiviral Res. 60, 17-25
26. Selgrade, M.K. et al. (1982) Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity. Infect. Immun. 38, 1046-1055